INDEGENE LTD. share price has zoomed 5% and is presently trading at Rs 672.4.
Meanwhile, the BSE HEALTHCARE index is at 43,227.7 (up 0.6%).
Among the top gainers in the BSE HEALTHCARE index today are POLY MEDICURE (up 10.7%) and ALEMBIC PHARMA (up 3.5%).
Jubilant Pharmova (down 3.0%) and MAX HEALTHCARE INSTITUTE (down 2.6%) are among the top losers today.
Over the last one year, INDEGENE LTD. has moved up from Rs 0.0 to Rs 672.4, registering a gain of Rs 672.4 .
On the other hand, the BSE HEALTHCARE index has moved up from 29,757.1 to 43,227.7, registering a gain of 45.3% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 157.2%), SUVEN PHARMACEUTICALS (up 117.2%) and Glenmark Pharma (up 92.7%).
Don't Miss: Key Information for Long-term Investors
The BSE Sensex is at 79,905.8 (up 1.0%).
The top gainers among the BSE Sensex today are L&T (up 3.9%) and SBI (up 3.6%). The most traded stocks in the BSE Sensex are Power Grid Corp. and Tata Steel.
In the meantime, NSE Nifty is at 24,194.3 (up 1.2%). ONGC and Bharat Electronics are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,930.8 to 79,905.8, registering a gain of 13,975.1 points (up 21.2%).
INDEGENE LTD. net profit fell {profitpercent} YoY to Rs 917 million for the quarter ended September 2024, compared to a profit of Rs {profitnumberprev} million a year ago. Net sales declined {salespercent} to Rs 6,868 million during the period as against Rs {salesnumberprev} million in {quarterprev}.
For the year ended March 2024, INDEGENE LTD. reported 26.5% increase in net profit to Rs 3,367 million compared to net profit of Rs 2,661 million during FY23. Revenue of the company grew 12.3% to Rs 25,896 million during FY24.
Equitymaster requests your view! Post a comment on "INDEGENE LTD. Gains 5%; BSE HEALTHCARE Index Up 0.6%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!